ArticleCancer immunology, immunotherapy : CII2020
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Abdul Rafeh Naqash et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.